Physician profile
Jonathan S Moore
NPI 1780095729
$917.50
in general payments reported to CMS, 2019-2025
24 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $60.39 · 2021: $85.02 · 2022: $130 · 2023: $43.69 · 2024: $145 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $154.73 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $81.82 | 2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $74.86 | 2021-2024 | Airsupra |
| Otsuka America Pharmaceutical, INC. | $72.98 | 2024-2025 | Rexulti |
| Xeris Pharmaceuticals, INC. | $63.21 | 2024-2025 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $60.70 | 2019-2022 | |
| Lilly USA, LLC | $38.86 | 2024 | Mounjaro, Zepbound |
| Allergan, INC. | $35.22 | 2019-2020 | |
| Novo Nordisk INC | $30.95 | 2025 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $28.88 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.27 | 2024 | |
| Aucta Pharmaceuticals, INC. | $24.72 | 2025 | Motpoly Xr |
| Dexcom, INC. | $23.89 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $23.80 | 2025 | |
| Edwards Lifesciences Corporation | $23.29 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.62 | 2025 | Evenity, Prolia |
| Advanced Respiratory, INC | $18.78 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.69 | 2019 | |
| Exact Sciences Corporation | $18.51 | 2025 | Cologuard Collection Kit |
| Philips North America LLC | $18.26 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.37 | 2019 | |
| Inspire Medical Systems, INC. | $14.95 | 2024 | Inspire |
| Abbott Laboratories | $13.78 | 2025 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.